Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis.
Lotte van OuwerkerkMaarten BoersPaul EmeryPascal Hendrik Pieter de JongRobert B M LandeweWillem F LemsJosef S SmolenPatrick VerschuerenThomas Wj HuizingaCornelia F AllaartSytske Anne BergstraPublished in: Annals of the rheumatic diseases (2022)
Based on these RA clinical trial arms with an initial GC bridging schedule, the probability of subsequent ongoing GC use following bridging is low.
Keyphrases
- clinical trial
- systematic review
- rheumatoid arthritis
- meta analyses
- case report
- electronic health record
- gas chromatography
- study protocol
- stem cells
- randomized controlled trial
- open label
- mass spectrometry
- systemic lupus erythematosus
- high resolution
- systemic sclerosis
- idiopathic pulmonary fibrosis
- liquid chromatography